HERCEPTIN for Metastatic neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where HERCEPTIN was used for Metastatic neoplasm.
Most Reported Side Effects for HERCEPTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 119 | 14.4% | 25 | 9 |
| Death | 96 | 11.6% | 96 | 5 |
| Diarrhoea | 64 | 7.7% | 6 | 29 |
| Nausea | 55 | 6.6% | 6 | 26 |
| Fatigue | 51 | 6.2% | 2 | 18 |
| Dyspnoea | 49 | 5.9% | 1 | 20 |
| Headache | 36 | 4.4% | 2 | 9 |
| Pain | 34 | 4.1% | 1 | 8 |
| Febrile neutropenia | 33 | 4.0% | 2 | 9 |
| Pyrexia | 30 | 3.6% | 0 | 17 |
| Rash | 30 | 3.6% | 0 | 12 |
| Asthenia | 29 | 3.5% | 1 | 9 |
| Vomiting | 29 | 3.5% | 2 | 14 |
| Metastases to central nervous system | 28 | 3.4% | 6 | 8 |
| Pain in extremity | 27 | 3.3% | 1 | 8 |
Other Indications for HERCEPTIN
Breast cancer (332)
Product used for unknown indication (175)
Breast cancer metastatic (169)
Her-2 positive breast cancer (48)
Gastric cancer (17)
Invasive ductal breast carcinoma (13)
Breast cancer female (11)
Palliative care (7)
Adjuvant therapy (6)
Breast cancer recurrent (6)
Other Drugs Used for Metastatic neoplasm
ATEZOLIZUMAB (130)
CARBOPLATIN (118)
PEMBROLIZUMAB (117)
PALBOCICLIB (116)
CISPLATIN (113)
CAPECITABINE (105)
BEVACIZUMAB (98)
NIVOLUMAB (88)
PACLITAXEL (88)
TRASTUZUMAB (88)